Journal
MULTIPLE SCLEROSIS JOURNAL
Volume 15, Issue 5, Pages 531-541Publisher
SAGE PUBLICATIONS LTD
DOI: 10.1177/1352458508101943
Keywords
extracellular matrix; multiple sclerosis; pathway analysis; proteome; systems biology
Categories
Funding
- Research on Psychiatric and Neurological Diseases and Mental Health
- Ministry of Health, Labour and Welfare of Japan [H17-020]
- Research on Health Sciences Focusing on Drug Innovation
- Japan Health Sciences Foundation [KH21101]
- Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT) [B18300118, S0801043]
- Nakatomi Foundation
Ask authors/readers for more resources
Background A recent proteomics study of multiple sclerosis (MS) lesion-specific proteome profiling clearly revealed a pivotal role of coagulation cascade proteins in chronic active demyelination. However, among thousands of proteins examined, nearly all of remaining proteins are yet to be characterized in terms of their implications in MS brain-lesion development. Methods By the systems biology approach using four different pathway analysis tools of bioinformatics, we studied molecular networks and pathways of the proteome dataset of acute plaques, chronic active plaques (CAP), and chronic plaques (CP). Results The database search on Kyoto Encyclopedia of Genes and Genomes (KEGG) and protein analysis through evolutionary relationships (PANTHER) indicated the relevance of extracellular matrix (ECM)-mediated focal adhesion and integrin signaling to CAP and CP proteome. KeyMolnet disclosed a central role of the complex interaction among diverse cytokine signaling pathways in brain-lesion development at all disease stages, as well as a role of integrin signaling in CAP and CP. Ingenuity pathway analysis (IPA) identified the network constructed with a wide range of ECM components, such as collagen, type I alpha 1, type I alpha 2, type VI alpha 2, type VI alpha 3, fibronectin 1, fibulin 2, laminin alpha 1, vitronectin, and heparan sulfate proteoglycan, as one of the networks highly relevant to CAP proteome. Conclusions Although four distinct platforms produced diverse results, they commonly suggested a role of ECM and integrin signaling in development of chronic lesions of MS. These in silico observations indicate that the selective blockade of the interaction between ECM and integrins in brain lesions in situ would be a target for therapeutic intervention in MS. Multiple Sclerosis 2009; 15: 531-541. http://msj.sagepub.com
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available